UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000023217 |
|---|---|
| Receipt number | R000026658 |
| Scientific Title | A phase II trial of conversion surgery after induction chemotherapy(Gemcitabine+nab-Paclitaxel) and chemoradiotherapy(RT+S-1) for the patients with locally advanced pancreatic cancer. |
| Date of disclosure of the study information | 2016/09/01 |
| Last modified on | 2021/01/19 11:01:19 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/07/18 21:35:06 | ||
| 2 | Update | 2020/04/14 11:24:19 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 3 | Update | 2020/04/14 11:28:34 | Recruitment status Date of IRB Last follow-up date |
|
| 4 | Update | 2020/04/14 11:29:54 | Number of participants that the trial has enrolled |
|
| 5 | Update | 2021/01/19 11:01:19 | Recruitment status |
